TYMS and mesothelioma: Pemetrexed, a cornerstone drug in mesothelioma treatment, inhibits the action of thymidylate synthase (TS), a key enzyme involved in the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP) [62].